DMD-Associated Cardiomyopathy: A Novel Mode of Cardiac Remodeling
AJAS · 2018 Biomedical and Health Sciences (inferred)
Overview
Background: Duchenne muscular dystrophy (DMD) is an X-linked recessive neuromuscular disease resulting from mutations in the dystrophin gene and it affects 1 in 5,000 males. In 2017, DMD-associated cardiomyopathy is the leading cause of premature deaths. Clinical data suggests DMD patients develop cardiac atrophy. The hypothesis of this study is DMD-associated cardiomyopathy develops secondary to dysregulation of signaling pathways involved in cardiomyocyte proliferation and cardiac atrophy. Methods: To test the study’s hypothesis, mdx mice, a murine model of DMD, were used. Histological, molecular and transcriptome analyses were undertaken to compare mdx to non-transgenic (NTg) or control hearts at various postnatal time points (P1, P4, P7, 2-week, 4-week and 8-week). Results: mdx mice have decreased heart size with diminished heart/body weight ratios, as compared to NTg controls (4.68 ± 0.07 vs. 5.10 ± 0.07, mdx vs. NTg, p<0.005, n=11 at 8 weeks). Immunohistochemical data reveal similar cardiomyocyte cell size (0.078 ± 0.001 vs. 0.078 ± 0.002, NTg vs. mdx, p=NS, n=3), suggesting there are fewer cells in mdx hearts. Transcriptome profiling revealed a significant reduction in proliferative markers with a corresponding increase in atrophy gene expression in mdx hearts. FACS analysis revealed mdx hearts have fewer cells than NTg hearts. Finally, mdx hearts have reduced protein expression of proliferation markers (Ki67 and pH3). Conclusion: Collectively, the study confirmed mdx mice have small, atrophic hearts due to dysregulation of cardiac proliferative and atrophic signaling pathways. This study sets the stage for investigation into novel therapeutic targets for the ame
Competition history
- AJAS 2018
Related projects
ISEF · 2018
Mast Cell Quantity and Localization in the Hearts, Quadriceps, and Diaphragms of a Duchenne Muscular Dystrophy Model
ISEF · 2025
Utrophin and Dystrophin Localization in Dystrophic Myotubes After Transduction With AAV rh10 Vectors Containing Microdystrophin Targeted to Striated Muscle Cells; Treatments for Duchenne Muscular Dystrophy
ISEF · 2014
The Role of a Novel Integrin Enhancing Protein Therapy to Protect Skeletal Muscle from Damage and Its Relationship to Fiber Type in a Mouse Model of Duchenne Muscular Dystrophy
ISEF · 2024
Creation of a Duchenne Muscular Dystrophy Myoblast Cell Culture Model by Knocking Out the Dystrophin Gene Using CRISPR/Cas-9 for High Throughput Drug Screening
ISEF · 2019
Healing a Broken Heart: Examining the Role of Polycomb Group Protein Asxl2 in Cardiomyocyte Proliferation
ISEF · 2016
The Effects of Fetal Troponin T on the Cardiac Remodeling of Hypertrophic Transgenic Hearts
ISEF · 2020
The Time Course of Murine Cardiomyocyte Maturation
ISEF · 2024
Strengthening Cardiomyocytes: Proliferation Independent Effects of Mechano-Transducer YAP1
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: AAAS Annual Meeting (Confex) / American Junior Academy of Science